Venue: The Posthouse Berlin Potsdamer Platz, Berlin, Germany
Website: go to
Fee: Not specified
Views: 60
Clinical lipidology continues to play a critical role in the prevention and treatment of cardiovascular disease worldwide. As the understanding of dyslipidemia, lipid metabolism and residual cardiovascular risk rapidly evolves, healthcare professionals require access to the latest evidence, clinical guidelines and therapeutic innovations.
LIPIDS 2026 has been developed to address these challenges by creating an international scientific forum dedicated to lipid disorders, preventive cardiology and metabolic disease. The congress will feature keynote lectures, expert panel discussions, case-based learning, scientific presentations and networking opportunities.
Clinical lipidology is the medical specialty focused on the diagnosis, prevention and treatment of lipid disorders associated with cardiovascular disease risk. This includes conditions such as elevated LDL cholesterol, hypertriglyceridemia, lipoprotein(a) abnormalities and familial hypercholesterolemia.
Modern clinical lipidology integrates preventive cardiology, metabolic medicine and evidence-based lipid management to reduce the burden of atherosclerotic cardiovascular disease (ASCVD), heart attack and stroke.
As cardiovascular disease remains one of the leading causes of mortality globally, advances in lipidology continue to play an increasingly important role in preventive healthcare.
Key Scientific Topics at LIPIDS 2026:
The scientific program at LIPIDS 2026 will cover a wide range of topics in clinical lipidology, dyslipidemia and cardiovascular prevention, including:
Dyslipidemia and cholesterol management
Lipoprotein(a) [Lp(a)]
Apolipoprotein B (ApoB)
Familial hypercholesterolemia
Atherosclerosis and ASCVD prevention
Triglycerides and residual cardiovascular risk
Preventive cardiology
Cardiometabolic disease
Obesity and lipid metabolism
Diabetes and cardiovascular risk
Lipidomics and precision medicine
Emerging lipid-lowering therapies
PCSK9 inhibitors
RNA-based lipid therapies
Inflammation and cardiovascular disease
Hypertension and metabolic syndrome
tags: cardiovascular disease